期刊文献+

抗骨质疏松治疗对骨量减少妇女的干预效果 被引量:7

Intervention effect of anti-osteoporosis therapy on osteopenia in women
原文传递
导出
摘要 目的 探讨抗骨质疏松治疗对绝经后骨量减少妇女的干预效果。方法 对31例绝经后骨量减少妇女进行抗骨质疏松治疗,常规给予阿仑膦酸钠、阿法骨化醇或骨化三醇、碳酸钙D3口服,比较治疗前后骨密度和骨代谢标志物的变化。结果 与治疗前相比,治疗6个月后腰椎L1~L4侧位和左股骨颈骨密度均增加,骨钙素、Ⅰ型前胶原N端肽、Ⅰ型胶原交联C端肽水平降低,而25羟基维生素D3水平升高(P〈0.05)。结论 采用抗骨质疏松治疗绝经后骨量减少妇女,能增加腰椎和股骨颈骨密度,有效预防骨量丢失,从而降低骨质疏松性骨折的发生。 Objective To investigate the intervention effect of anti‐osteoporosis therapy on osteopenia in postmenopausal women .Methods A total of 31 postmenopausal women with osteopenia received anti‐osteoporosis therapy including alendronate ,alfacalcidol or calcitriol ,calcium carbonate . The changes of bone mineral density (BMD) and bone metabolism makers were compared before and after treatment .Results Compared with before ,the BMD values of lumbar spine 1‐4 and left femoral neck were increased ,the levels of osteocalcin ,collagen type Ⅰ N‐terminal peptide andβ‐crosslaps were decreased ,and the level of 25‐hydroxyvitamin D3 was gradually increased after treatment for 6 months (P<0 .05) .Conclusion The anti‐osteoporosis therapy in the treatment of postmenopausal women with osteopenia can effectively increase the BMD values of lumbar spine and femoral neck ,prevent bone loss and decrease the incidence of osteoporotic fractures .
作者 王树金 孔丹辉 吴树华 陈建红 戎琳晔 蒋波逸 WANG Shujin KONG Danhui WU Shuhua et al(Department of Orthopaedics, People's Hospital of Danyang, Danyang 212300, CHINA)
出处 《江苏医药》 CAS 2016年第20期2230-2232,共3页 Jiangsu Medical Journal
关键词 骨质疏松 骨密度 绝经期 Osteopenia Bone mineral density Menopause
  • 相关文献

参考文献7

  • 1原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17. 被引量:1833
  • 2Pasco JA,Seeman E,Henry MJ,et al.The population burden of fractures originates in women with osteopenia,not osteoporosis[J].Osteoporos Int,2006,17(9):1404-1409. 被引量:1
  • 3Miller PD,Siris ES,Barrett-Connor E,et al.Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry:evidence from the National Osteoporosis Risk Assessment[J].J Bone Miner Res,2002,17(12):2222-2230. 被引量:1
  • 4连帆,王于,杨岫岩,詹钟平,叶玉津,陈冬莹,邱茜,李昊.绝经后骨质疏松治疗方法的近期疗效观察与比较[J].中山大学学报(医学科学版),2011,32(3):379-382. 被引量:14
  • 5North American Menopause Society.Management of osteoporosis in postmenopausal women:2006position statement of The North American Menopause Society[J].Menopause,2006,13(3):340-367. 被引量:1
  • 6Bonnick S,Broy S,Kaiser F,et al.Treatment with alendronate plus calcium,alendronate alone,or calcium alone for postmenopausal low bone mineral density[J].Curr Med Res Opin,2007,23(6):1341-1349. 被引量:1
  • 7Chapurlat RD,Palermo L,Ramsay P,et al.Risk of fracture among women who lose bone density during treatment with alendronate.The Fracture Intervention Trial[J].Osteoporos Int,2005,16(7):842-848. 被引量:1

二级参考文献14

  • 1Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis [J].Am J Med, 1993, 94(6) : 646-650. 被引量:1
  • 2Riggs BL, Melton LJ lII. Involutional osteoporosis [J]. N Engl J Med, 1986, 314(26) : 1676-1686. 被引量:1
  • 3Vujasinovic-Stupar N, Milic N, Petrovic-Rackov L, et al. Efficacy and safety of once monthly ibandronate treatment in patients with reduced bone mineral density- ESTHER study [J].Srp Arh Celok Lek, 2010, 138(1- 2) : 56-61. 被引量:1
  • 4Iwamoto J, Sato Y, Uzawa M, et al. Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis [J]. Ther Clin Risk Manag, 2010, 26(6): 201-206. 被引量:1
  • 5Kanis JA, Melton LJ III, Christiansen C, et al. The diagnosis of osteoporosis [J]. J Bone Miner Res, 1994,9(8): 1137-1141. 被引量:1
  • 6Englund U, Nordstrom P, Nilsson J, et al. Physical activity in middle-aged women and hip fracture risk: the UFO study [J]. Osteoporos Int, 2011, 22(2): 499- 505. 被引量:1
  • 7Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture intervention trial research group [J]. Lancet, 1996, 348(9041) : 1535-1541. 被引量:1
  • 8MacLean C, Newberry S, Maglione M, etal. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis [J]. Ann Intern Med, 2008, 148 (3): 197-213. 被引量:1
  • 9Black DM, Bilezikian JP, Ensrud KE, et al. One year of alendronate after one year of parathyroid hormone for osteoporosis [J]. N Engl J Med, 2005, 353 (6): 555- 565. 被引量:1
  • 10Tolcos M, Tikellis C, Rees S, et al. Ontogeny of calcitonin receptor mRNA and protein in the developing central nervous system of the rat [J]. J Comp Neurol, 2003, 456(1) : 29-38. 被引量:1

共引文献1844

同被引文献87

引证文献7

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部